Literature DB >> 717349

Hemostatic alterations in inflammatory bowel disease: response to therapy.

A M Lake, J Q Stauffer, M J Stuart.   

Abstract

Twelve patients with acute, untreated inflammatory bowel disease (IBD) were followed prospectively for coagulation and platelet function. With no symptomatic coagulopathy, abnormalities were found in all patients. With acute diseases, elevations of fibrinogen (9/12), factor V (8/12), and factor VIII (6/12) were common. Depressions of antithrombin III levels were also observed acutely (8/12). Abnormalities of platelets were both quantitative and qualitative. Thrombocytosis was present (11/12), and abnormalities in the rate and percent platelet aggregation were seen (9/10). During therapy, factors V and VIII, antithrombin III levels, and the quantitative and qualitative platelet abnormalities returned towards normal in direct correlation with sedimentation rate and clinical disease activity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 717349     DOI: 10.1007/bf01072463

Source DB:  PubMed          Journal:  Am J Dig Dis        ISSN: 0002-9211


  16 in total

1.  THROMBOEMBOLIC PHENOMENA IN ULCERATIVE COLITIS. TWO CASE REPORTS.

Authors:  E L KEHOE; K L NEWCOMER
Journal:  Arch Intern Med       Date:  1964-05

2.  MEASUREMENT OF PLATELET ADHESIVENESS. A SIMPLE IN VITRO TECHNIQUE DEMONSTRATING AN ABNORMALITY IN VON WILLEBRAND'S DISEASE.

Authors:  E W SALZMAN
Journal:  J Lab Clin Med       Date:  1963-11

3.  COMPARISON OF CLINICAL FINDINGS AND HEMATOLOGIC CHANGES IN PATIENTS WITH CHRONIC ULCERATIVE COLITIS.

Authors:  R G FARMER; H H SCUDAMORE; E D BAYRD
Journal:  Am J Gastroenterol       Date:  1963-12       Impact factor: 10.864

4.  Aggregation of blood platelets by adenosine diphosphate and its reversal.

Authors:  G V BORN
Journal:  Nature       Date:  1962-06-09       Impact factor: 49.962

5.  Refractory state of platelet aggregation with major operations.

Authors:  J R O'Brien; M Etherington; S Jamieson
Journal:  Lancet       Date:  1971-10-02       Impact factor: 79.321

6.  A micromethod for free erythrocyte porphyrins: the FEP test.

Authors:  S Piomelli
Journal:  J Lab Clin Med       Date:  1973-06

7.  Thrombocytosis in ulcerative colitis and Crohn's disease.

Authors:  I Talstad; K Rootwelt; E Gjone
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

8.  Thrombocytosis in chronic inflammatory bowel disease.

Authors:  D A Morowitz; L W Allen; J B Kirsner
Journal:  Ann Intern Med       Date:  1968-05       Impact factor: 25.391

Review 9.  Hypercoagulability.

Authors:  J Hirsh
Journal:  Semin Hematol       Date:  1977-10       Impact factor: 3.851

10.  Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment.

Authors:  C Merskey; G J Kleiner; A J Johnson
Journal:  Blood       Date:  1966-07       Impact factor: 22.113

View more
  33 in total

Review 1.  Mesenteric arterial thrombosis as a complication of Crohn's disease.

Authors:  P Sanghavi; A Paramesh; A Dwivedi; T Markova; T Phan
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

2.  Predictive value of inflammatory and coagulation parameters in the course of severe ulcerative colitis.

Authors:  R K Linskens; A A van Bodegraven; M Schoorl; H A Tuynman; P Bartels
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

3.  Circulating cell-derived microparticles in Crohn's disease.

Authors:  Patrick Chamouard; Dominique Desprez; Bénédicte Hugel; Corinne Kunzelmann; Carole Gidon-Jeangirard; Michel Lessard; René Baumann; Jean-Marie Freyssinet; Lélia Grunebaum
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

4.  What is the impact of resistance to activated protein C (Leiden mutation to factor V) in inflammatory bowel disease?

Authors:  Emma Attvall; Attila Frigyesi; Berit Sternby
Journal:  Int J Colorectal Dis       Date:  2006-01-13       Impact factor: 2.571

Review 5.  Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.

Authors:  Franco Scaldaferri; Stefano Lancellotti; Marco Pizzoferrato; Raimondo De Cristofaro
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

6.  Anti-cardiolipin antibodies in patients with inflammatory bowel disease.

Authors:  B W Aichbichler; W Petritsch; G A Reicht; H H Wenzl; A J Eherer; T A Hinterleitner; P Auer-Grumbach; G J Krejs
Journal:  Dig Dis Sci       Date:  1999-04       Impact factor: 3.199

7.  Internal carotid artery occlusion in association with Crohn's disease.

Authors:  A Prior; F A Strang; P J Whorwell
Journal:  Dig Dis Sci       Date:  1987-09       Impact factor: 3.199

8.  Anti-cardiolipin and anti-beta2-glycoprotein I antibodies in patients with inflammatory bowel disease.

Authors:  I E Koutroubakis; E Petinaki; E Anagnostopoulou; H Kritikos; I A Mouzas; E A Kouroumalis; O N Manousos
Journal:  Dig Dis Sci       Date:  1998-11       Impact factor: 3.199

Review 9.  Venous thrombosis and prothrombotic factors in inflammatory bowel disease.

Authors:  Fernando Magro; João-Bruno Soares; Dália Fernandes
Journal:  World J Gastroenterol       Date:  2014-05-07       Impact factor: 5.742

10.  Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease.

Authors:  J C Souto; E Martínez; M Roca; J Mateo; J Pujol; D González; J Fontcuberta
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.